Loading...
Association of Fetal Growth Restriction With Neurocognitive Function After Repeated Antenatal Betamethasone Treatment vs Placebo: Secondary Analysis of the ACTORDS Randomized Clinical Trial
IMPORTANCE: Repeated doses of antenatal betamethasone are recommended for women at less than 32 weeks’ gestation with ongoing risk of preterm birth. However, concern that this therapy may be associated with adverse neurocognitive effects in children with fetal growth restriction (FGR) remains. OBJEC...
Na minha lista:
| Udgivet i: | JAMA Netw Open |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Medical Association
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6484607/ https://ncbi.nlm.nih.gov/pubmed/30707225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2018.7636 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|